Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

Europe - FRA:NVJP - BE0974320526 - Common Stock

16.74 EUR
-0.2 (-1.18%)
Last: 10/30/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NVJP. NVJP was compared to 68 industry peers in the Chemicals industry. NVJP has a medium profitability rating, but doesn't score so well on its financial health evaluation. NVJP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NVJP was profitable.
NVJP had a positive operating cash flow in the past year.
Of the past 5 years NVJP 4 years were profitable.
NVJP had a positive operating cash flow in each of the past 5 years.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of NVJP (1.50%) is comparable to the rest of the industry.
NVJP has a Return On Equity of 6.30%. This is in the better half of the industry: NVJP outperforms 60.29% of its industry peers.
NVJP has a better Return On Invested Capital (6.40%) than 66.18% of its industry peers.
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROIC 6.4%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

NVJP's Profit Margin of 0.80% is in line compared to the rest of the industry. NVJP outperforms 47.06% of its industry peers.
With a Operating Margin value of 2.57%, NVJP perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
With a Gross Margin value of 7.76%, NVJP is not doing good in the industry: 83.82% of the companies in the same industry are doing better.
NVJP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

NVJP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, NVJP has about the same amount of shares outstanding.
The number of shares outstanding for NVJP remains at a similar level compared to 5 years ago.
The debt/assets ratio for NVJP is higher compared to a year ago.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 2.79 indicates that NVJP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.79, NVJP is in the better half of the industry, outperforming 66.18% of the companies in the same industry.
NVJP has a debt to FCF ratio of 50.79. This is a negative value and a sign of low solvency as NVJP would need 50.79 years to pay back of all of its debts.
NVJP has a Debt to FCF ratio (50.79) which is comparable to the rest of the industry.
NVJP has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NVJP (1.10) is worse than 83.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Altman-Z 2.79
ROIC/WACC1.05
WACC6.08%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.37. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NVJP (1.37) is worse than 69.12% of its industry peers.
NVJP has a Quick Ratio of 1.37. This is a bad value and indicates that NVJP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.72, NVJP is not doing good in the industry: 80.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.72
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

NVJP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.12%.
Measured over the past years, NVJP shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.85% on average per year.
NVJP shows a small growth in Revenue. In the last year, the Revenue has grown by 2.55%.
NVJP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.21% yearly.
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%

3.2 Future

Based on estimates for the next years, NVJP will show a small growth in Earnings Per Share. The EPS will grow by 7.13% on average per year.
NVJP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.36% yearly.
EPS Next Y19.15%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
EPS Next 5Y7.13%
Revenue Next Year-2.58%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.81 indicates a correct valuation of NVJP.
Based on the Price/Earnings ratio, NVJP is valued a bit cheaper than 76.47% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.19. NVJP is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 12.52, the valuation of NVJP can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NVJP indicates a somewhat cheap valuation: NVJP is cheaper than 75.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of NVJP to the average of the S&P500 Index (22.50), we can say NVJP is valued slightly cheaper.
Industry RankSector Rank
PE 14.81
Fwd PE 12.52
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NVJP is valued a bit cheaper than the industry average as 66.18% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as NVJP.
Industry RankSector Rank
P/FCF 73.12
EV/EBITDA 8.41
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y12.31%
EPS Next 3Y10.33%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.05%, NVJP has a reasonable but not impressive dividend return.
NVJP's Dividend Yield is a higher than the industry average which is at 3.10.
NVJP's Dividend Yield is comparable with the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

The dividend of NVJP has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NVJP pays out 93.29% of its income as dividend. This is not a sustainable payout ratio.
NVJP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP93.29%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
NVJP.DE Dividend Payout.NVJP.DE Dividend Payout, showing the Payout Ratio.NVJP.DE Dividend Payout.PayoutRetained Earnings

UMICORE

FRA:NVJP (10/30/2025, 7:00:00 PM)

16.74

-0.2 (-1.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners35.32%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.12B
Revenue(TTM)16.10B
Net Income(TTM)128.82M
Analysts66.67
Price Target14.26 (-14.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP93.29%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.15%
PT rev (3m)6.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)23.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)2.89%
Valuation
Industry RankSector Rank
PE 14.81
Fwd PE 12.52
P/S 0.26
P/FCF 73.12
P/OCF 8.78
P/B 2.02
P/tB 2.48
EV/EBITDA 8.41
EPS(TTM)1.13
EY6.75%
EPS(NY)1.34
Fwd EY7.99%
FCF(TTM)0.23
FCFY1.37%
OCF(TTM)1.91
OCFY11.39%
SpS65.35
BVpS8.29
TBVpS6.75
PEG (NY)0.77
PEG (5Y)N/A
Graham Number14.52
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROCE 8.18%
ROIC 6.4%
ROICexc 8.19%
ROICexgc 9.07%
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
FCFM 0.35%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score5
Asset Turnover1.87
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Debt/EBITDA 3.22
Cap/Depr 144.97%
Cap/Sales 2.57%
Interest Coverage 4.12
Cash Conversion 67.19%
Profit Quality 43.79%
Current Ratio 1.37
Quick Ratio 0.72
Altman-Z 2.79
F-Score5
WACC6.08%
ROIC/WACC1.05
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
EPS Next Y19.15%
EPS Next 2Y12.31%
EPS Next 3Y10.33%
EPS Next 5Y7.13%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%
Revenue Next Year-2.58%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.36%
EBIT growth 1Y136.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.86%
EBIT Next 3Y23.57%
EBIT Next 5Y16.17%
FCF growth 1Y136.84%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-3.36%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%

UMICORE / NVJP.DE FAQ

What is the ChartMill fundamental rating of UMICORE (NVJP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NVJP.DE.


What is the valuation status for NVJP stock?

ChartMill assigns a valuation rating of 5 / 10 to UMICORE (NVJP.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for UMICORE?

UMICORE (NVJP.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for NVJP stock?

The Price/Earnings (PE) ratio for UMICORE (NVJP.DE) is 14.81 and the Price/Book (PB) ratio is 2.02.


What is the financial health of UMICORE (NVJP.DE) stock?

The financial health rating of UMICORE (NVJP.DE) is 3 / 10.